ClinConnect ClinConnect Logo
Search / Trial NCT01335503

Effect of AN-PEP Enzyme on Gluten Digestion

Launched by DSM FOOD SPECIALTIES · Apr 13, 2011

Trial Information

Current as of July 21, 2025

Completed

Keywords

Gluten

ClinConnect Summary

In this trial, the effect of AN-PEP enzyme on gastrointestinal breakdown of gluten will be investigated in healthy subjects. In addition, it will be assessed if meal calories can affect the efficacy of AN-PEP. Subjects receive intragastrically, either AN-PEP or placebo, with either a high or a low caloric meal in a double-blind, randomized, placebo-controlled, cross-over fashion. Gastrointestinal fluid will be sampled to measure breakdown of gluten.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Male/female
  • Age ≥ 18 years but \< 45 years
  • Hormonal contraceptive treatment
  • Subject has read and understood the information provided on the study and given written informed consent
  • Exclusion Criteria:
  • Any medical condition or laboratory test result that in the opinion of the investigators may interfere with the study and may jeopardise the health status of the participant
  • pregnancy or lactation
  • women not treated with hormonal contraceptive treatment

About Dsm Food Specialties

DSM Food Specialties is a leading global provider of innovative food ingredients and solutions, dedicated to enhancing the quality and sustainability of food products. As a division of DSM, a global science-based company, DSM Food Specialties leverages cutting-edge research and development to create high-performance ingredients that improve flavor, texture, and nutritional value while addressing the evolving needs of consumers and food manufacturers. With a commitment to sustainability and health, DSM Food Specialties actively engages in clinical trials to validate the efficacy and safety of its products, ensuring they meet the highest standards of quality and regulatory compliance in the food industry.

Locations

Maastricht, , Netherlands

Patients applied

0 patients applied

Trial Officials

Ad Masclee, Prof Dr

Principal Investigator

Maastricht University Medical Center

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials